Northern Research and Development

Northern Research and Development (NRD) is a specialized biotechnology company focused on the discovery and early-stage development of novel therapeutic modalities for oncology and immunology. The company leverages its proprietary NRD-Discovery Engine to identify high-affinity binders and optimize lead candidates across various classes, including small molecules and biologics. NRD's current internal pipeline is primarily focused on next-generation immune checkpoint modulators and targeted therapies for refractory solid tumors. In addition to its internal programs, the company provides strategic R&D services and collaborative research opportunities to global pharmaceutical partners. Northern Research and Development aims to bridge the gap between academic discovery and clinical application through rigorous preclinical validation.